Regenerative Medicine as Applied to General Surgery

Giuseppe Orlando(Forest Institute), Kathryn J. Wood(University of Oxford), Paolo De Coppi(Wake Forest University), Pedro M. Baptista(Wake Forest University), Kyle Binder(Wake Forest University), Khalil N. Bitar(NHS Blood and Transplant), Christopher K. Breuer, Luke Burnett(Burn Institute), George J. Christ(Forest Institute), Alan C. Farney(NHS Blood and Transplant), Marina Figliuzzi, James H. Holmes(Burn Institute), Kenneth L. Koch, Paolo Macchiarini(Wake Forest University), Sayed-Hadi Mirmalek Sani(Wake Forest University), Emmanuel C. Opara(Wake Forest University), Andrea Remuzzi, Jeffrey Rogers(NHS Blood and Transplant), Justin M. Saul(Forest Institute), Dror Seliktar(Wake Forest University), Keren Shapira‐Schweitzer(Forest Institute), Tom L. Smith, Daniel Solomon, Mark Van Dyke(Wake Forest University), James J. Yoo(Forest Institute), Yuanyuan Zhang(Wake Forest University), Anthony Atala(Wake Forest University), Robert J. Stratta(NHS Blood and Transplant), Shay Söker(Wake Forest University)
Annals of Surgery
February 11, 2012
Cited by 113Open Access
Full Text

Abstract

In Brief The present review illustrates the state of the art of regenerative medicine (RM) as applied to surgical diseases and demonstrates that this field has the potential to address some of the unmet needs in surgery. RM is a multidisciplinary field whose purpose is to regenerate in vivo or ex vivo human cells, tissues, or organs to restore or establish normal function through exploitation of the potential to regenerate, which is intrinsic to human cells, tissues, and organs. RM uses cells and/or specially designed biomaterials to reach its goals and RM-based therapies are already in use in several clinical trials in most fields of surgery. The main challenges for investigators are threefold: Creation of an appropriate microenvironment ex vivo that is able to sustain cell physiology and function in order to generate the desired cells or body parts; identification and appropriate manipulation of cells that have the potential to generate parenchymal, stromal and vascular components on demand, both in vivo and ex vivo; and production of smart materials that are able to drive cell fate. This review illustrates the art of regenerative medicine as applied to surgery and demonstrates that this field has the potential to address some of the unmet needs in the treatment of surgical diseases.


Related Papers

No related papers found

Powered by citation graph analysis